Snehal Naik
Bioscience (China)(CN)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Helicobacter pylori-related gastroenterology studies, Immunodeficiency and Autoimmune Disorders
Most-Cited Works
- → Pharmacological Activation of Liver X Receptors Promotes Reverse Cholesterol Transport In Vivo(2005)377 cited
- → Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis(2019)224 cited
- → Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study(2021)100 cited
- → Current State of Imaging Protein-Protein Interactions In Vivo with Genetically Encoded Reporters(2007)100 cited
- → Dual-Color Click Beetle Luciferase Heteroprotein Fragment Complementation Assays(2010)74 cited
- → Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant β-Catenin Activation in Colon Cancer(2009)68 cited
- → Both the Peroxisome Proliferator‐Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL‐Derived Cholesterol(2009)65 cited
- → Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease(2019)63 cited
- → Regulation of Cysteinyl Leukotriene Type 1 Receptor Internalization and Signaling(2004)55 cited
- → Peroxisome Proliferator-Activated Receptor-α Activation Promotes Macrophage Reverse Cholesterol Transport Through a Liver X Receptor–Dependent Pathway(2011)54 cited